Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium

Journal of Nuclear Medicine

Volumn 41, Issue 6, 2000, Pages 1102-1107

  Imahashi, Kenichi ^b   Morishita, Kenichi ^b   Kusuoka, Hideo ^b   Yamamichi, Yoshihiro ^b   Hasegawa, Shinji ^b   Hashimoto, Katsuji ^b   Shirakami, Yoshifumi ^b   Kato Azuma, Makoto ^b   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Hypoxia; Ischemia; Myocardial stunning; Radioisotopes

Indexed keywords

4,9 DIAZA 3,3,10,10 TETRAMETHYLDODECAN 2,11 DIONE DIOXIME; NITROIMIDAZOLE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEART MUSCLE ISCHEMIA; HYPOXIA; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIOACTIVITY; RAT; STUNNED HEART MUSCLE;

ANIMALS; ANOXIA; HEART; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; OXIMES; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034082545     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Martin GV, Caldwell JH, Graham MM, et al. Non-invasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography, J Nucl Med. 1992;33:2202-2208.
2. Shelton ME, Dence CS, Hwang D-R, Welch MJ. Myocardial kinetics of fluorine-18 misonidazole: a maker of hypoxic myocardium. J Nucl Med. 1989;30:351-358.
3. Martin GV, Biskupiak JE, Caldwell JH, Rasey JS, Kroll KA. Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia. J Nucl Med. 1993;34:918-924.
4. Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS 181321), in normoxic, hypoxic, ischemic and stunned myocardium. J Nucl Med. 1994;35:1371-1376.
5. Ng CK, Sinusas AJ, Zaret B, Soufer R. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia. Circulation. 1995;92:1261-1268.
6. Fukuchi K, Kusuoka H, Watanabe Y, Fujiwara T, Nishimura T. Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole. J Nucl Med. 1996;37:761-766.
7. Rumsey WL, Kuczynski B, Patel B, et al. SPECT imaging of ischaemic myocardium using a techenetium-99m-nitroimidazole ligand. J Nucl Med. 1995;36:1445-1450.
8. Shi CQ, Sinusas AJ, Dione DP, et al. Technetium-99m nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia. J Nucl Med. 1995;36:1078-1086.
9. Archer CM, Edwards B, Kelly JD, King AC, Burke JF, Riley ALM. Technetium labelled agents for imaging tissue hypoxia in vivo. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Padova, Italy: SGE Ditoriali: 1995;535-539.
10. 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia. J Nucl Med. 1999;40:854-861.
11. Tatsumi M, Yutani K, Kusuoka H, Nishimura T. Technetium-99m HL91 uptake as a tumor hypoxia marker: relationship to tumor blood flow. Eur J Nucl Med. 1999;26:91-94.
12. 99mTc-HL91: effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation. 1997;95:1892-1899.
13. Johnson G III, Nguyen KN, Liu Z, Okada RD. Technetium 99m-HL-91: a potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion. J Nucl Cardiol. 1998;5:285-294.
14. 99mTc-HL91: "Hot spot" detection of ischemic myocardium in vivo by gamma camera imaging. Circulation. 1998;97: 2557-2566.
15. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med. 1995;36:1043-1050.
16. Okada RD, Nguyen KN, Lauinger M, Allton IL, Johnson G III. Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow. Am Heart J. 1996;132:108-115.
17. Godfrey K. Compartmental models and their application. London, UK: Academic Press; 1983.
18. Fukuchi K, Kusuoka H, Yutani K, Hasegawa S, Nishimura T. Assessment of reperfused myocardium using a new ischemia-avid imaging agent, technetium-99m HL91: comparison with myocardial glucose uptake. Eur J Nucl Med. 1998;25:361-366.
19. Okada RD, Johnson G III, Nguyen KN, Carlson LR, Beju D. HL-91-technetium-99m: a new marker of viability in ischemic myocardium. J Nucl Cardiol. 1999;6:306-315.
20. Rumsey WL, Patel B, Linder KE. Effect of graded hypoxia on retention of technetium-99m-nitroheterocycle in perfused rat heart. J Nucl Med. 1995;36:632-636.
21. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
22. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest. 1987;79:950-961.
23. Neirinckx RD, Canning LR, Piper IM, et al. Technetium-99m d,I-NMPAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med. 1987;28:191-202.
24. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med. 1995;22:265-280.
25. 99mTc-HL91 [abstract]. Eur J Nucl Med. 1997;24:943.